Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDT
2801
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $838K | ﹤0.01% |
80,075
-124,000
| -61% | -$1.47M |
|
2802
Cass Information Systems
CASS
$729M
| $832K | ﹤0.01% |
19,211
+2,779
| +17% | +$133K |
|
2803
Collegium Pharmaceutical
COLL
$1.16B
| $831K | ﹤0.01% |
34,649
+4,427
| +15% | +$117K |
|
2804
Agilysys
AGYS
$3.14B
| $831K | ﹤0.01% |
10,071
+375
| +4% | +$30.3K |
|
2805
Concentrix
CNXC
$1.56B
| $828K | ﹤0.01% |
6,811
+1,071
| +19% | +$145K |
|
2806
Manitowoc
MTW
$519M
| $825K | ﹤0.01% |
48,250
-76
| -0.2% | -$1.14K |
|
2807
Alamos Gold
AGI
$12B
| $824K | ﹤0.01% |
67,382
+20,200
| +43% | +$219K |
|
|
BIG
2808
DELISTED
Big Lots, Inc.
BIG
| $824K | ﹤0.01% |
75,159
-89,720
| -54% | -$1.36M |
|
|
NUVL
2809
DELISTED
Nuvalent
NUVL
| $822K | ﹤0.01% |
31,523
+2,085
| +7% | +$61.7K |
|
2810
American Vanguard Corp
AVD
$71.2M
| $822K | ﹤0.01% |
37,576
+6,422
| +21% | +$138K |
|
2811
Grab
GRAB
$15.2B
| $822K | ﹤0.01% |
272,976
-25,837
| -9% | -$85.8K |
|
2812
Byline Bancorp
BY
$1.81B
| $821K | ﹤0.01% |
37,984
+11,903
| +46% | +$278K |
|
|
SOVO
2813
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $820K | ﹤0.01% |
49,167
+21,453
| +77% | +$301K |
|
2814
Vroom Inc
VRM
$36.7M
| $819K | ﹤0.01% |
11,396
+88
| +0.8% | +$7.11K |
|
|
FORG
2815
DELISTED
ForgeRock, Inc.
FORG
| $818K | ﹤0.01% |
39,691
-129,211
| -77% | -$2.62M |
|
2816
PetMed Express
PETS
$42.5M
| $817K | ﹤0.01% |
50,325
+44,904
| +828% | +$846K |
|
2817
Pediatrix Medical
MD
$2.03B
| $816K | ﹤0.01% |
54,737
+2,856
| +6% | +$43.3K |
|
2818
Phreesia
PHR
$707M
| $815K | ﹤0.01% |
25,234
+7,514
| +42% | +$264K |
|
|
QVCGA
2819
DELISTED
QVC Group Inc Series A
QVCGA
| $815K | ﹤0.01% |
16,494
+9,949
| +152% | +$893K |
|
|
MRSN
2820
DELISTED
Mersana Therapeutics
MRSN
| $814K | ﹤0.01% |
7,921
-1,363
| -15% | -$191K |
|
2821
Huron Consulting
HURN
$2.43B
| $809K | ﹤0.01% |
10,072
+4,777
| +90% | +$347K |
|
2822
CALL
Aclaris Therapeutics
ACRS
$835M
| $809K | ﹤0.01% |
+100,000
| New | +$1.27M |
|
2823
Sinclair Inc
SBGI
$1.01B
| $808K | ﹤0.01% |
47,072
+7,001
| +17% | +$122K |
|
2824
MillerKnoll
MLKN
$1.66B
| $806K | ﹤0.01% |
39,399
-435
| -1% | -$9.78K |
|
2825
PRA Group
PRAA
$672M
| $806K | ﹤0.01% |
20,680
-27,294
| -57% | -$1.07M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.